Biofrontera reports preliminary approximate revenues for the month of September 2021
01 oct. 2021 07h44 HE
|
Biofrontera AG
Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Biofrontera reports Q1 2021 financial results
11 mai 2021 10h41 HE
|
Biofrontera AG
Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Biofrontera announces conference call to be held on May 20, 2020 to discuss first quarter 2020 financial results
12 mai 2020 11h00 HE
|
Biofrontera AG
Leverkusen, Germany, May 12, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Organizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph Dünwald
31 janv. 2020 11h38 HE
|
Biofrontera AG
Leverkusen, Germany, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Biofrontera to participate at the Lake Street Capital Markets 2019 Best Ideas Growth (BIG) Conference
05 sept. 2019 11h45 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...
Biofrontera Announces Conference Call on August 27, 2019 to Discuss Half-year 2019 Financial Results
14 août 2019 05h30 HE
|
Biofrontera AG
Leverkusen, Germany, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Biofrontera nominates new candidate for the Supervisory Board
04 juin 2019 10h00 HE
|
Biofrontera AG
Leverkusen, Germany, June 04, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
Biofrontera to present at the Baader Investment Conference
19 sept. 2018 04h03 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be...